John B Moriarty's Net Worth
$6.59 Million
Who is John B Moriarty?
John B Moriarty has an estimated net worth of $6.59 Million. This is based on reported shares across multiple companies, which include Olema Pharmaceuticals, Inc., Mirati Therapeutics, Inc., ALEXION PHARMACEUTICALS INC, and PORTOLA PHARMACEUTICALS INC.
SEC CIK
John B Moriarty's CIK is 0001564621
Past Insider Trading and Trends
2015 was John B Moriarty's most active year for acquiring shares with 7 total transactions. John B Moriarty's most active month to acquire stocks was the month of January. 2016 was John B Moriarty's most active year for disposing of shares, totalling 13 transactions. John B Moriarty's most active month to dispose stocks was the month of January. 2014 saw John B Moriarty paying a total of $8,406,920.00 for 65,268 shares, this is the most they've acquired in one year. In 2014 John B Moriarty cashed out on 54,606 shares for a total of $7,323,677.29, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Olema Pharmaceuticals, Inc. (OLMA) Snapshot price: $11.85
EVP, Ch. Legal Officer & Sec.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19 - Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Chief Legal OfficerJohn B Moriarty used to own units in Common Stock but no longer holds any shares there. In the year 2023 John B Moriarty acquired a total of 22,297 shares in Mirati Therapeutics, Inc. at a cost of $824,989.00, John also disposed a total of 72,335 shares of Mirati Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -72.33K |
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +45.17% | 22.3K |
$37.00 | $824,989.00 | 71.66K |
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALEXION PHARMACEUTICALS INC No price found
EVP & General CounselJohn B Moriarty owns 74,537 units of Common Stock, par value $.0001 per share.acquired a total of 132,425 shares in ALEXION PHARMACEUTICALS INC at a cost of $3,736,000.00, John also disposed a total of 67,866 shares of ALEXION PHARMACEUTICALS INC equalling to $10,689,791.91.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +49.34% | 24.63K |
$115.70 | -$389,099.10 | 74.54K |
Feb 6 - Feb 8
| |||
Form 4
| -2.46% | -1.26K |
$117.26 | -$147,864.86 | 49.91K |
Feb 5
| |||
Form 4
| +10.10% | 4.7K |
$131.66 | -$237,515.50 | 51.17K |
Feb 27 - Mar 1
| |||
Form 4
| -0.36% | -167.00 |
$126.84 | -$21,182.28 | 46.48K |
Feb 9
| |||
Form 4
| -7.05% | -3.54K |
$125.79 | -$445,031.09 | 46.64K |
Feb 6 - Feb 7
| |||
Form 4
| -2.04% | -1.04K |
$118.61 | -$123,828.84 | 50.18K |
Dec 12
| |||
Form 4
| -0.26% | -135.00 |
$137.14 | -$18,513.90 | 51.23K |
Aug 8
| |||
Form 4
| -1.76% | -918.00 |
$135.72 | -$124,590.96 | 51.36K |
Jun 13
| |||
Form 4
| +7.84% | 3.8K |
$138.91 | -$166,832.65 | 52.28K |
Feb 26 - Feb 29
| |||
Form 4
| +17.32% | 7.16K |
$140.38 | -$646,024.71 | 48.5K |
Feb 4 - Feb 8
| |||
Form 4
| -2.23% | -943.00 |
$182.73 | -$172,311.20 | 41.34K |
Dec 11
| |||
Form 4
| -0.32% | -135.00 |
$190.01 | -$25,651.35 | 42.28K |
Aug 7
| |||
Form 4
| +30.81% | 9.99K |
$145.55 | -$133,376.68 | 42.42K |
Aug 5
| |||
Form 4
| -2.74% | -914.00 |
$170.00 | -$155,380.00 | 32.43K |
Jun 11
| |||
Form 4
| +24.52% | 6.57K |
$180.34 | -$50,495.20 | 33.34K |
Feb 27 - Mar 2
| |||
Form 4
| -5.27% | -1.49K |
$171.15 | -$255,013.50 | 26.78K |
Feb 10
| |||
Form 4
| +34.85% | 7.3K |
$174.16 | -$253,402.80 | 28.27K |
Feb 5 - Feb 9
| |||
Form 4
| -14.55% | -3.57K |
$195.53 | -$698,042.10 | 20.96K |
Dec 11
| |||
Form 4/A
| -28.96% | -10.00K |
$92.65 | -$926,500.00 | 24.53K |
Scheduled
|
Oct 6
| ||
Form 4
|
—
|
0
|
$141.07 | -$968,437.23 | 24.53K |
Scheduled
|
Oct 27
| ||
Form 4
|
—
|
0
|
$137.32 | -$833,500.00 | 24.53K |
Scheduled
|
Oct 6
| ||
Form 4
| +10.35% | 2.3K |
—
|
—
| 24.53K |
Feb 28
| |||
Form 4
| +29.26% | 5.03K |
$155.60 | -$161,197.96 | 22.23K |
Feb 6 - Feb 7
| |||
Form 4
| +14.67% | 2.2K |
—
|
—
| 17.2K |
Feb 6
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PORTOLA PHARMACEUTICALS INC No price found
EVP, General CounselJohn B Moriarty used to own units in Common Stock but no longer holds any shares there. From 2018 to 2020 John B Moriarty acquired a total of 60,000 shares in PORTOLA PHARMACEUTICALS INC, John also disposed a total of 25,061 shares of PORTOLA PHARMACEUTICALS INC equalling to $463,247.26.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -12.89K |
$18.00 | -$232,074.00 |
0
|
Jul 2
| |||
Form 4
| -7.97% | -4.33K |
$9.68 | -$41,885.36 | 49.98K |
Scheduled
|
Mar 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +31.39% | 12.71K |
$12.89 | -$45,682.16 | 53.18K |
Scheduled
|
Jan 31 - Feb 3
| ||
Form 4
| -9.71% | -4.30K |
$33.42 | -$143,605.74 | 39.95K |
Scheduled
|
Mar 4
| ||
Form 4
| +75.00% | 18.75K |
—
|
—
| 43.75K |
Jan 31
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||